首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Collagen prolyl hydroxylation in WI-38 fibroblast cultures: Action of hydralazine
Authors:Katherine H Chen  Mercedes A Paz  Paul M Gallop
Institution:(1) The Department of Biological Chemistry and Orthopaedic Surgery, Harvard Medical School and Harvard School of Dental Medicine, 300 Longwood Avenue, 02115 Boston, Massachusetts;(2) The Children's Hospital Medical Center, 300 Longwood Avenue, 02115 Boston, Massachusetts
Abstract:Summary The action of hydralazine on collagen prolyl hydroxylation was studied in a cell culture system using WI-38 fibroblasts. The prolyl hydroxylation level was determined by a method involving the digestion of collagen by bacterial collagenase and the examination of specific peptides. The presence of low concentrations of hydralazine (0.2 mM) in both “young” and “old” fibroblast cultures strongly inhibited collagen prolyl hydroxylation. The degree of inhibition was greater in serum-deficient cultures. No significant improvement in the degree of hydroxylation was observed by increasing either ascorbate or iron levels in the hydralazine-containing cultures in which hydroxylation was inhibited. Some of the reported side effects of hydralazine seen in patients might be related to its inhibitory effects on mixed function oxidative (MFO) hydroxylation systems. While the ascorbate dependence of the prolyl hydroxylase system of WI-38 decreased with the “age” of the culture, hydralazine inhibition of hydroxylation was dramatic with cultures of all “ages”. This work was supported by NIH grants nos. AM15671, AM1675 and HD07376, and fellowship no. HD01998.
Keywords:collagen  prolyl hydroxylation  fibroblast  hydralazine
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号